CompoAtlas

Cardioliv

Food supplement declared in France, declaration No 2020-2-260

Cardioliv is a food supplement declared in France. Status: retrait du marché annoncé pour le 3 November 2028. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
New Stefal Holding
Status
Retrait du marché annoncé pour le 3 November 2028
Form
Comprimé
Daily dose
2
Directions for use
Prendre 1 comprimé 2 fois par jour avec un verre d'eau.
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Femmes enceintes, Sous anticoagulants
Objectives stated by the manufacturer (these are not authorised claims)
Artères et cholestérol

Declaration 167505, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Olea europaea L.FruitAutre extrait sec168 mg
Coriandrum sativum L.FruitExtrait sec aqueux100 mg
Terminalia chebula Retz.FruitExtrait sec aqueux100 mg
Allium sativum L.BulbeExtrait sec aqueux50 mg

Other active ingredients

NamePer day
Ubiquinonenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Chlorhydrate de thiamineVitamine B1 (thiamine)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011

Additives

E460, E341, E470b

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Ne convient pas aux femmes enceintes ou qui allaitent et aux enfants de moins de 18 ans. Déconseillé aux personnes sous traitement anticoagulant.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Enter to analyse, Shift+Enter for a new line